companydata.dkSpeciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS: Financial statements 2022
CVR: 38420712
Speciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS (CVR 38420712) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,833,846 and a net result of DKK 1,114,284 compared with DKK 633,199 the year before. That is an increase of 16.2% compared with the year before. Equity amounted to DKK 1,480,460. The solvency ratio was 50.6%. The company had 4 employees in the financial year.
- Gross Profit
- 4,833,846 kr.
- Profit/Loss
- 1,114,284 kr.
- Equity
- 1,480,460 kr.
- Total Assets
- 2,923,168 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.8 mio. | 1.1 mio. | 1.5 mio. | 4 |
| 2021 | - | 4.2 mio. | 633 t. | 966 t. | 4 |
| 2020 | - | 3.7 mio. | 632 t. | 833 t. | 3 |
| 2019 | - | 3.3 mio. | 379 t. | 431 t. | 3 |
| 2018 | - | 3 mio. | 167 t. | 193 t. | 3 |
Keep an eye on Speciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Speciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS has published its annual report for 2021. Gross profit came to DKK 4,159,529, and the net result was DKK 633,199.
About Speciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS
Speciallægepraksis i øre-næse-halssygdomme, Nykøbing Falster ApS is a Danish company of the type Anpartsselskab based in Nykøbing F, founded in 2017. The company is registered under the industry Speciallægers aktiviteter. The management consists of Didde Trærup Schnack and Tine Amstrup. The company is owned by DiMA ApS and Tine Amstrup Holding ApS. The company has 4 employees. In 2025, the company reported a gross profit of DKK 5,150,698 and a net result of DKK 1,832,221 compared with DKK 1,468,875 the year before. Equity amounted to DKK 2,281,535.